Supervisory Board

Supervisory Board Chairman (appointed until 2023)

Dr. Gerald Hommel, born on 21. January 1959, place of residence: Mainz (Rhineland-Palatinate), member of the Supervisory Board and Supervisory Board Chairman since 2014

Profession: Independent pharmaceuticals entrepreneur and Managing Shareholder of pharmarissano Arzneimittel GmbH

German citizenship

• Undergraduate study of economic sciences at the universities of Mainz and Würzburg, degree in business management (1985)
• 1985 - 1997 Pharmaceutical wholesaling, most recently Managing Director at PHOENIX Pharma Einkauf GmbH, Dreieich
• 1997 - 1999 Management Board member of GESKO eG, Gerlingen (purchasing cooperative)
• Since 1999: Independent pharmaceuticals entrepreneur
• Since 2004: Managing Shareholder of pharmarissano Arzneimittel GmbH
• Doctorate in economic and social history from the University of Frankfurt am Main (2014)
• Qualified Supervisory Board Examination by Deutsche Börse AG (2018)
• Qualified Supervisory Board Financial Expert Examination by Deutsche Börse AG (2022)

Dr. Hommel is Chairman of the Executive Committee and the Nomination Committee, as well as Deputy Chairman of the Audit Committee.

Dr. Hommel does not hold any further mandates on statutory Supervisory Boards or comparable German or foreign controlling entities of commercial enterprises.

Deputy Chairwoman of the Supervisory Board (appointed until 2023)

Dr. Barbara Ooms-Gnauck, born on 28. October 1957, place of residence: Herleshausen (Hesse), member of the Supervisory Board since 2014

Profession: Attorney and specialist lawyer for administrative law at Gnauck Rechtsanwälte GbR

Belgian citizenship

• Study of chemistry and ecototrophology at the University of Bonn, degree in ecototrophology (1983)
• Study of jurisprudence of the University of Göttingen, First State Examination (2001)
• Probationary Training Period at the District Court of Kassel, Second State Examination (2004)
• Attorney (2004)
• 2005 – 2010: Attorney, partner at GKMP Rechtsanwälte Steuerberater Wirtschaftsprüfer
• Since 2010: Shareholder in and attorney at Gnauck Rechtsanwälte GbR
• Doctorate awarded by the University of Constance (2012)
• Specialist lawyer for administration law (2016)

Dr. Ooms-Gnauck does not hold any further mandates on statutory Supervisory Boards or comparable German or foreign controlling entities of commercial enterprises.

(appointed until 2023)

Uwe Andreas Krämer, born on 27. October 1978, place of residence: Aarau (Switzerland), member of the Supervisory Board since 2015

Profession: Group CFO of enterprise software company Scandit AG, Zürich

German citizenship

• Degree in business information technology from the Technical University of Darmstadt (2006)
• 2006 – 2008: Investment Banking Division, Goldman Sachs, Frankfurt
• 2008 – 2014: Venture & growth capital investment professional focusing on software and internet technology, ViewPoint Capital, Frankfurt/Zürich
• 2016 – 2018: Managing Director & CFO/CCO of enterprise software company Fision AG, Zürich
• Since 2014: Growth capital investor focusing on cleantech, Zouk Capital, London
• Since 2018: CFO/VP Finance & Operations of enterprise software company Scandit AG, Zürich

Mr. Krämer is a member of the Nomination Committee of the Supervisory Board.

Mr. Krämer does not hold any further mandates on statutory Supervisory Boards or comparable German or foreign controlling entities of commercial enterprises.

(appointed until 2023)

Winfried Klar, born on 10. October 1954, place of residence: Oldenburg (Germany), member of the Supervisory Board since 2013

Profession: Management consultant

German citizenship

• Degree in business administration from the University of Münster (1979)
• 1980 – 1990: Auditor and tax consultant PwC Düsseldorf
• 1991 – 1992: Head of Group development EVONIK (formerly RAG)
• 1993 – 2003: Managing Director, Management Board member, CFO at various companies
• 2004 – 2009: Managing Director and CFO of VESTOLIT GmbH & Co KG, Marl
• 2009 – 2013: Managing Director and CFO of MAUSER Holding GmbH, Brühl
• 2013 – 2019: Management consulting in the Middle East, KMC Klar Management Consultancies, Dubai

Mr. Klar has been the Chairman of the Audit Committee of the Supervisory Board since 2016.

Mr. Klar does not hold any further mandates on statutory Supervisory Boards or comparable German or foreign controlling entities of commercial enterprises.

(appointed until 2023)

Dr. Eberhard Kroth, born on 15. September 1956, place of residence: Obernburg (Bavaria), member of the Supervisory Board since 2013

Profession: Managing Shareholder of RoPro4.0 GmbH, automation technology

German citizenship

• Undergraduate studies and doctorate at the Technical University of Darmstadt (1985)
• 1986 – 1994: Company officer and Technical Director at Reis Robotics, Reis GmbH & Co KG
• 1994 – 2010: Managing Director at Reis Robotics, Reis GmbH & Co KG
• 2010 – 2016: Managing Director at Reis Group Holding GmbH
• 2015 – 2016: Managing Director & Chief Technical Officer (CTO) of KUKA Industries GmbH
• Since 2017: Managing Shareholder of RoPro4.0 GmbH, automation technology

Dr. Kroth is a member of the Audit Committee.

Dr. Kroth does not hold any further mandates on statutory Supervisory Boards or comparable German or foreign controlling entities of commercial enterprises.

(appointed until 2023)

Dr. Burkhard Wichert, born on 05. December 1961, place of residence: Bielefeld (North Rhine-Westphalia), member of the Supervisory Board since 2021

Profession: Founder and managing director of pos pharma GmbH

German citizenship

• Studied pharmacy at the Westfälische Wilhelms University in Münster (1987)
• Doctorate in pharmaceutical technology (1989)
• 1990 - 2001 various positions in research and development and production at ASTA Medica
• 2002 - 2016 various positions in operations including commercial and operational head of global contract manufacturing at Baxter Halle (Westphalia, Germany)
• MBA from Buckinghamshire Chilterns University College (2007)
• 2016 - 2019 head of operations EMEA at Baxter Zurich
• Since 2019 founder and managing director of pos pharma GmbH
• Qualified Supervisory Board Examination by Deutsche Börse AG (2021)

Dr. Wichert does not hold any further mandates on statutory Supervisory Boards or comparable German or foreign controlling entities of commercial enterprises.